Scantek Anticipates Expansion of Breastcare Usuage in the 13 Municipalities of Baixada Fluminense in Brazil.

Business & Health Editors

DENVILLE, N.J.--(BUSINESS WIRE)--July 20, 2001

Scantek Medical, Inc. (OTCBB: SKML.OB) announced today, that its Brazilian managers and medical representatives met at the Health Municipal Partnership for Baixada Fluminense (CISBAF) to discuss the expansion of the Women's Health Project (includes BreastCare) for the Baixada Fluminense territory.

This expansion has the potential to triple the previously announced $1.5 million purchase order which management anticipate will be finalized when the educational program is completed in Nova Iguacu. Baixada Fluminense is a region in the northern section of the State of Rio de Janeiro composed of 13 municipalities with an aggregate population of 4 million people (30% of the population of the State of Rio de Janeiro) and 71 health centers.

CISBAF is the representative for all the municipalities to the Health Ministry of Brazil. CISBAF is the most important health organization in Baixada Fluminense. The Mayor of Nova Iguacu who also is the President of CISBAF will utilize approximately US$ 25 million from the Health Ministry of Brazil for a three-year Women's Health Project in Nova Iguacu.

It is of utmost importance to receive CISBAF participation due to their bargaining power and political representation with the Brazilian Federal Government, which could significantly impact the expansion of the Women's Health Project. Also, through CISBAF the Federal health program will support 100% of the resources needed for health projects.

As previously announced, BreastCare received its official classification number from the Brazilian Ministry de Saude (Health) establishing BreastCare as the only breast cancer device approved in the Nova Iguacu's Screening Program. The BreastCare educational program has commenced with the hiring and training of medical personnel for the Women's Health Program in the City of Nova Iguacu, the seventh (7th) largest municipality in Brazil with a population of approximately 1 million. The Company will continue to hire additional medical personnel with the rapid expansion of the activities in Nova Iguacu.

Scantek is a medical device company engaged in developing, manufacturing, selling and licensing of products and devices to assist in the diagnosis and early detection of disease. At the present time, the Company is focused on manufacturing, selling, and licensing the BreastCare/BreastAlert Differential Temperature Sensor device. The BreastCare/BreastAlert is a low cost, adjunctive, single-use, non-invasive, 15-minute test for the detection of breast disease including breast cancer.

Certain statements in this press release with respect to future expectations

and plans may be regarded as "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties and are subject to change at any time. The Company's actual results could differ materially from such statements.